Phathom Pharmaceuticals, Inc.
PHAT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $175M | $55.2M | +217% |
| Operating income | −$160M | −$277M | +42.3% |
| Net income | −$221M | −$334M | +33.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $84.7M | $49.5M | +71.1% |
| Operating income | −$100K | −$15.3M | +99.3% |
| Net income | −$13.9M | −$30.0M | +53.7% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Phathom's revenue in FY2025?
- $175M in FY2025 (Fiscal year ended Dec 31, 2025), +217% vs $55.2M a year earlier, per its 10-K filed Feb 2026.
- Was Phathom profitable in FY2025?
- No: net income was −$221M and operating income −$160M in FY2025.
- What was Phathom's revenue in Q3 2026?
- $84.7M (+71.1% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.